HLA Class II Specificity Assessed by High-Density Peptide Microarray Interactions.
Journal
Journal of immunology (Baltimore, Md. : 1950)
ISSN: 1550-6606
Titre abrégé: J Immunol
Pays: United States
ID NLM: 2985117R
Informations de publication
Date de publication:
01 07 2020
01 07 2020
Historique:
received:
03
03
2020
accepted:
22
04
2020
pubmed:
3
6
2020
medline:
12
3
2021
entrez:
3
6
2020
Statut:
ppublish
Résumé
The ability to predict and/or identify MHC binding peptides is an essential component of T cell epitope discovery, something that ultimately should benefit the development of vaccines and immunotherapies. In particular, MHC class I prediction tools have matured to a point where accurate selection of optimal peptide epitopes is possible for virtually all MHC class I allotypes; in comparison, current MHC class II (MHC-II) predictors are less mature. Because MHC-II restricted CD4
Identifiants
pubmed: 32482711
pii: jimmunol.2000224
doi: 10.4049/jimmunol.2000224
pmc: PMC7313418
doi:
Substances chimiques
Epitopes, T-Lymphocyte
0
HLA-DR Antigens
0
Peptides
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
290-299Informations de copyright
Copyright © 2020 by The American Association of Immunologists, Inc.
Références
Science. 2018 Mar 23;359(6382):1355-1360
pubmed: 29567706
J Proteome Res. 2017 Mar 3;16(3):1300-1314
pubmed: 28121444
Mol Cell Proteomics. 2016 Apr;15(4):1360-80
pubmed: 26831522
Nat Biotechnol. 2019 Nov;37(11):1283-1286
pubmed: 31611696
Nat Protoc. 2019 Jun;14(6):1687-1707
pubmed: 31092913
PLoS One. 2011;6(11):e26781
pubmed: 22073191
Clin Exp Immunol. 2004 Feb;135(2):247-52
pubmed: 14738452
Nature. 2017 May 11;545(7653):243-247
pubmed: 28467828
PLoS One. 2013 Jul 23;8(7):e68902
pubmed: 23894373
Nucleic Acids Res. 2019 Jan 8;47(D1):D339-D343
pubmed: 30357391
Nature. 2015 Apr 30;520(7549):692-6
pubmed: 25901682
Curr Opin Immunol. 1999 Apr;11(2):209-13
pubmed: 10322158
Nucleic Acids Res. 2020 Jan 8;48(D1):D948-D955
pubmed: 31667505
Immunity. 2019 Oct 15;51(4):766-779.e17
pubmed: 31495665
PLoS One. 2007 Aug 29;2(8):e796
pubmed: 17726526
Autoimmun Rev. 2012 Jan;11(3):180-90
pubmed: 21621003
PLoS One. 2014 Apr 23;9(4):e94892
pubmed: 24760079
BMC Bioinformatics. 2008 Dec 12;9 Suppl 12:S22
pubmed: 19091022
Nat Biotechnol. 1999 Oct;17(10):974-8
pubmed: 10504697
Science. 2014 May 9;344(6184):641-5
pubmed: 24812403
J Immunol. 2020 Jul 1;205(1):290-299
pubmed: 32482711
Mol Cell Proteomics. 2012 Dec;11(12):1790-800
pubmed: 22984286
Tissue Antigens. 2003 Nov;62(5):378-84
pubmed: 14617044
Methods Mol Biol. 2016;1394:189-209
pubmed: 26700050
J Mol Biol. 2003 Aug 15;331(3):623-41
pubmed: 12899833
Nat Biotechnol. 2017 Feb 8;35(2):97
pubmed: 28178261
Immunome Res. 2009 May 05;5:2
pubmed: 19416502
Nucleic Acids Res. 2017 Jul 3;45(W1):W344-W349
pubmed: 28407117
BMC Immunol. 2005 Dec 05;6:24
pubmed: 16329759
Immunogenetics. 2019 Jul;71(7):445-454
pubmed: 31183519
BMC Bioinformatics. 2007 Jul 04;8:238
pubmed: 17608956
J Immunol. 1989 Aug 15;143(4):1268-73
pubmed: 2787362
BMC Bioinformatics. 2009 Sep 18;10:296
pubmed: 19765293